Skip to main content

My Medical and Public Health Wish List for 2021

2020 was a difficult year for many people all over the world (if only we had the benefit 20-20 hindsight at the start of the year). Here is a list of 10 developments I would like to see in 2021.

  1. A much better government response to the Covid-19 pandemic with interventions introduced at the right time and correct scale.
  2. A rapid rollout of the Covid-19 vaccination programme so that target groups such as older people, those with long-term health problems, NHS staff and other key workers such as teachers and people working in high-risk occupations can be protected.
  3. Awareness that the Covid-19 pandemic must be ended globally, not just in richer countries, and ensuring that people across the globe have access to the vaccines that will be introduced in 2021.
  4. Better government policies to address key health challenges and risk factors for poor health such as poor diets, lack of exercise, and obesity; along with the wider determinants of health such as housing, education, poverty, and employment.
  5. Greater support for our schools and teachers who have been outstanding in 2020 in trying to keep children educated during the midst of a global pandemic.
  6. Respect for science and a reduction in the anti-science conspiracy theories that are some common on social media and in everyday conversations.
  7. Greater support and recognition of the role played by primary care in ensuring good access to healthcare and improved health outcomes globally.
  8. A positive relationship with our European neighbours and with the European Union. 
  9. An adequate replacement for the ERASMUS programme so that or students can benefit from the social, cultural and education opportunities that placements at universities in other European countries can bring.
  10. An improvement in the IT systems that staff working in the NHS have to use. Poor IT leads to high levels of stress among NHS staff, and wastes valuable time and money that could be used to better effect elsewhere.

This is just a small list. Let me know what’s on your wish list for 2021. 


Comments

Post a Comment

Popular posts from this blog

The Hidden Cost of Cheaper NHS Contracts: Losing Community Trust

NHS budgets are under considerable pressure. It is therefore unsurprising that many NHS Integrated Care Boards (ICBs) In England will aim to prioritise price in contract awards, But this approach is a significant threat to community-centred healthcare. While competitive tendering is a legally required, an excessive focus on costs in awarding NHS contracts risks overshadowing key factors such as established community trust, local expertise, and the long-term impact on continuity of care. This shift towards cheaper, often external, commercial providers threatens to cut the links between communities and their local health services. The argument that competitive tendering is solely about legal compliance, and not cost, is undermined by the very nature of such tendering, which by design encourages the lowest bid. This approach risks eroding the social fabric of local healthcare provision, where established relationships and understanding of specific community needs are essential. Establishe...
1 comment
Read more

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments fo...
5 comments
Read more

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...
Post a Comment
Read more